179 related articles for article (PubMed ID: 28446397)
1. [Expression of asparagine synthetase in relapsed or refractory extranodal NK/T cell lymphoma].
Wu SJ; Li YF; Wang YJ
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):465-469. PubMed ID: 28446397
[TBL] [Abstract][Full Text] [Related]
2. Asparagine synthetase expression and its potential prognostic value in patients with NK/T cell lymphoma.
Li Y; Zhang X; Hu T; Han L; Li R; Wen J; Zhang M
Oncol Rep; 2014 Aug; 32(2):853-9. PubMed ID: 24913732
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of HMGB1 is prognostic of poor survival in patients with relapsed/refractory T/NK-CL.
Wang C; Wang Y; Cao J; Sun X; He X; Sun P; Gao T; Huang J; Li Z
Ann Hematol; 2021 Sep; 100(9):2293-2302. PubMed ID: 33991204
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
Yamaguchi M; Suzuki R; Kwong YL; Kim WS; Hasegawa Y; Izutsu K; Suzumiya J; Okamura T; Nakamura S; Kawa K; Oshimi K
Cancer Sci; 2008 May; 99(5):1016-20. PubMed ID: 18294294
[TBL] [Abstract][Full Text] [Related]
5. Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro.
Liu WJ; Wang H; Peng XW; Wang WD; Liu NW; Wang Y; Lu Y
Onco Targets Ther; 2018; 11():6605-6615. PubMed ID: 30349294
[TBL] [Abstract][Full Text] [Related]
6. L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature.
Jaccard A; Petit B; Girault S; Suarez F; Gressin R; Zini JM; Coiteux V; Larroche C; Devidas A; Thiéblemont C; Gaulard P; Marin B; Gachard N; Bordessoule D; Hermine O
Ann Oncol; 2009 Jan; 20(1):110-6. PubMed ID: 18701429
[TBL] [Abstract][Full Text] [Related]
7. The role of Skp2 in extranodal NK/T-cell lymphoma.
Guo HQ; Pu XX; Guo CC; Rao HL; Li HR; Lin TY
Chin J Cancer; 2010 May; 29(5):567-71. PubMed ID: 20426910
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
Yamaguchi M; Kwong YL; Kim WS; Maeda Y; Hashimoto C; Suh C; Izutsu K; Ishida F; Isobe Y; Sueoka E; Suzumiya J; Kodama T; Kimura H; Hyo R; Nakamura S; Oshimi K; Suzuki R
J Clin Oncol; 2011 Nov; 29(33):4410-6. PubMed ID: 21990393
[TBL] [Abstract][Full Text] [Related]
9. [Retrospective Analysis of Clinical Features and Prognosis of 84 Patients with Extranodal NK/T Cell Lymphoma in One Center].
Yang QS; Zhao SH; Jiang Y; Jiang TY; Yuan SZ; Su H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1390-1396. PubMed ID: 29070113
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.
Kim SJ; Kim BS; Choi CW; Choi J; Kim I; Lee YH; Kim JS
Ann Oncol; 2007 Aug; 18(8):1382-7. PubMed ID: 17693651
[TBL] [Abstract][Full Text] [Related]
11. [Expression of PDGFRA and CMYC in extranodal NK/T-cell lymphoma and their prognostic implications].
Chen YP; Zhu WF; Lin JY; He TM; Ma HM; Lu JP; Ye XA; Xu CW; Chen G
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):825-830. PubMed ID: 28056296
[No Abstract] [Full Text] [Related]
12. [Advances of treatment for extranodal NK/T-cell lymphoma --- review].
Zhang SS; Wei M; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1075-8. PubMed ID: 21867647
[TBL] [Abstract][Full Text] [Related]
13. L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type.
Yong W; Zheng W; Zhu J; Zhang Y; Wang X; Xie Y; Lin N; Xu B; Lu A; Li J
Ann Hematol; 2009 Jul; 88(7):647-52. PubMed ID: 19107482
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
Jia J; Song Y; Lin N; Liu W; Ping L; Zheng W; Wang X; Xie Y; Tu M; Zhang C; Ying Z; Deng L; Ding N; Zhu J
Ann Hematol; 2016 Dec; 95(12):2023-2031. PubMed ID: 27595760
[TBL] [Abstract][Full Text] [Related]
15. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
[TBL] [Abstract][Full Text] [Related]
16. The landscape of new drugs in extranodal NK/T-cell lymphoma.
Wang L; Li LR; Zhang L; Wang JW
Cancer Treat Rev; 2020 Sep; 89():102065. PubMed ID: 32653806
[TBL] [Abstract][Full Text] [Related]
17. Extranodal natural killer/T-cell lymphoma with long-term survival and repeated relapses: does it indicate the presence of indolent subtype?
Kim SJ; Park Y; Kim BS; Kim I; Ko YH; Kim WS
Korean J Hematol; 2012 Sep; 47(3):202-6. PubMed ID: 23071475
[TBL] [Abstract][Full Text] [Related]
18. [Clinical differences between primary nasopharyngeal NK/T-cell lymphoma and primary nasal cavity NK/T-cell lymphoma with nasopharynx extension].
Liu WX; Liu YP; Jin J; Wang SL; Fang H; Ren H; Song YW; Chen B; Lu NN; Li N; Tang Y; Qi SN; Tang Y; Wang WH; Li YX
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):56-62. PubMed ID: 30678418
[No Abstract] [Full Text] [Related]
19. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells.
Krejci O; Starkova J; Otova B; Madzo J; Kalinova M; Hrusak O; Trka J
Leukemia; 2004 Mar; 18(3):434-41. PubMed ID: 14724653
[TBL] [Abstract][Full Text] [Related]
20. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]